These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8327426)

  • 21. [Analysis of fenoterol efficacy given as an aerosol using various mouth pieces].
    Ciszek J; Kazimierczak A; Wesołowski S
    Pneumonol Alergol Pol; 1993; 61(3-4):120-6. PubMed ID: 8364424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Osmolarity of solutions used in nebulization].
    Portel L; Tunon de Lara JM; Vernejoux JM; Weiss I; Taytard A
    Rev Mal Respir; 1998 Apr; 15(2):191-5. PubMed ID: 9608990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of bronchospasm in impairment of bronchial permeability in bronchial asthma in attack-free period].
    Nefedov VB; Popova LA
    Klin Med (Mosk); 1999; 77(12):30-3. PubMed ID: 10684212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duovent inhaler v Inhalets in patients with asthma and chronic bronchitis.
    Town I
    N Z Med J; 1987 Nov; 100(836):726. PubMed ID: 2967935
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combined bronchodilating therapy of respiratory diseases complicated with bronchial obstruction].
    Shmelev EI
    Ter Arkh; 2007; 79(3):17-21. PubMed ID: 17526189
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacodynamics of inhalation broncholytic agents introduced in a single dose by nebulizer in patients with severe exacerbation of bronchial asthma].
    Tsoĭ AN; Apkhipov VV
    Ter Arkh; 2002; 74(3):17-21. PubMed ID: 11980113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
    Lee TY; Chen CM; Lee CN; Chiang YC; Chen HY
    Am J Health Syst Pharm; 2005 Apr; 62(8):828-33. PubMed ID: 15821276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways.
    Duvivier DH; Chiap P; Crommen J; Lekeux P
    Vet Res; 1997; 28(6):557-64. PubMed ID: 9428149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of water as a diluent for bronchodilator nebuliser solutions.
    Kwong T; Town I; Windom H; Beasley R
    N Z Med J; 1990 Jun; 103(892):290-1. PubMed ID: 2366999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled bronchodilator's in asthma: low or high dose?
    Haahtela T; Ahokas I; Ahonen A; van Assendelft A; Havu M; Havu K; Kava T; Kotaniemi J; Mönkäre S; Valta R
    Ann Allergy; 1991 Feb; 66(2):175-80. PubMed ID: 1825266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnesium sulfate in management of bronchial asthma].
    Emel'ianova AV; Goncharova VA; Sinitsina TM
    Klin Med (Mosk); 1996; 74(8):55-8. PubMed ID: 9036213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new inhalation system for bronchodilatation. Study of the acceptance of the Ingelheim M inhaler in chronic obstructive respiratory tract diseases].
    Mütterlein R; Schmidt G; Fleischer W; Freund E
    Fortschr Med; 1990 Apr; 108(11):225-8. PubMed ID: 2141590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmotic challenges in the assessment of bronchial hyperresponsiveness.
    Anderson SD; Smith CM
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S43-6. PubMed ID: 1672245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of various inhalation aids in children with bronchial asthma].
    Schöni MH; Robinson S
    Schweiz Med Wochenschr; 1989 Nov; 119(46):1636-7. PubMed ID: 2514457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma.
    Sposato B; Barzan R; Calabrese A; Franco C
    J Asthma; 2008 Jun; 45(5):397-401. PubMed ID: 18569233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The function profile of compressed-air and ultrasonic nebulizers.
    Wu HL; Lin YZ; Wu WF; Huang FY
    Acta Paediatr Taiwan; 2003; 44(5):264-8. PubMed ID: 14964980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 39. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications.
    Newhouse MT; Dolovich M
    Chest; 1987 May; 91(5 Suppl):58S-64S. PubMed ID: 3552472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.